Esteemed bankers in attendance included representatives from Cain Brothers, Cantor Fitzgerald, Fifth Third, Greenhill & Co., Oppenheimer & Co. Inc., Solomon Partners, Stephens Inc., Stout and Stifel Financial Corp. Additionally, private equity sponsors such as Ally Bridge, Centre Lane Partners, H.I.G. Capital, KKR, Sentinel Capital Partners, Sheridan Capital Partners, Varsity Healthcare Partners, VSS, and Webster Equity were present.

The day also included a panel discussion on the current state of the healthcare private equity market. Moderated by Chris Sheaffer, Reed Smith’s Global Vice-Chair of Private Equity at Reed Smith and Nicole Aiken-Shaban, a partner in the firm’s Life Sciences & Healthcare practice, participants discussed issues of critical importance to dealmaking in the healthcare sector including perspectives on deal flow over the first half of 2024, the public perception and narrative around private equity involvement in healthcare, potential effects of the 2024 presidential election on the government’s role in oversight of private equity healthcare investment, managing buyer vs. seller expectations given current market dynamics, and forecasts for deal activity through the rest of the year.

Reed Smith is a market leader in advising clients through healthcare deals of varying sizes and complexity and through each phase of the investment life cycle, with a keen understanding of regulatory frameworks affecting each sector of the industry. The firm relies on the decades-long experience of its sophisticated private equity and subject-matter health care teams handling the corporate, financial, and regulatory aspects of these types of transactions, including critical regulatory due diligence necessary to identify and mediate transactional risk, to assist its private equity clients and their portfolio companies with their most strategic transactions around the world.

A recording of this panel a can be heard by downloading Reed Smith’s Dealmaker Insights podcast.